Market Pulse
Daily · Sep 17, 2026 · data.go.kr + ECOS
KOSPI
6,715.41
-2.56 (-0.04%)
KOSDAQ
822.18
+6.20 (+0.76%)
KOSPI 200
1,058.27
-1.78 (-0.17%)
USD/KRW
1,382.20
Mirae Asset Securities published a company analysis report on DAEWOONG PHARMA (069620) titled "Compelling valuation".
Summary
Covers DAEWOONG PHARMA (069620).
Covered stock
More on 069620
Early Nabota shipments lift earningsMirae Asset Securities · Jul 31, 2026Initiating Coverage: New Business Potential; Discount to NarrowKB Securities · May 27, 2026Efforts to streamline prescription drug channels underwayMirae Asset Securities · May 14, 2026Strong margin growthMirae Asset Securities · Feb 11, 2025